Healthcare -
Biotechnology - NASDAQ - US
$ 18.13
6.27 %
$ 1.44 B
Market Cap
-4.2
P/E
VRDN - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss VRDN - Viridian Therapeutics, Inc.
338 K
LAST VALUE
103.79%
2 YEAR CAGR
158.16%
5 YEAR CAGR
10.93%
10 YEAR CAGR